TLRY
Tilray Brands, Inc.
$4.42
+0.03 (+0.68%)
At close · Jul 10
Market Cap
$515.15M
Shares
116,548,663
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$4.42
Open$4.44
Day$4.38–4.53
52W$4.20–23.20
Avg vol 30d3.7M
Short int17.8M · 15.3% float · 5.3d
Short vol43%
Last earningsApr 1, 2026
DataJan 2020–Jul 2026
Filing10-Q · Apr 1
Up next
FQ1-27 quarter ends
~Aug 31, 2026
Est
filed Apr 1, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 15 · calm
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−49%
below
Price vs 50-day avg
−14%
below
RSI (14)
37
neutral
MACD trend
Positive
52-week position
1%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−12%
trailing
6-month return
−54%
trailing
YTD return
−51%
this year
Relative strength
−64%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $5 › 200d $9 — 200d above 50d
Institutional flow
Accumulating
6 of 213 funds reported for Jun 30 · net +99 sh shares · +1 new
Insider flow
Distributing
Net -$232.9K over 90 days · 100% sells
Short interest
Falling
15.27% of float · ▼ -2.6% MoM · 5.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
213 holders — near 1-yr high, broad support
Squeeze score
65
elevated · 0–100
Fundamentals
Revenue growth
+4%
Y/Y
Gross margin
29%
expanding
EPS growth
−645%
Y/Y
Free cash flow
$-139.2M
Balance sheet
$36.0M
net cash
Quant / Vol
risk profile
Volatility
128%
annualized · 1-yr
Max drawdown
−79%
past year
ATR
5.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−49%
Bearish
Price vs 50-day avg
−14%
Bearish
RSI (14)
37
Neutral
MACD trend
Positive
Bullish
52-week position
1%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $5 › 200d $9 — 200d above 50d
Institutional flow
Accumulating
6 of 213 funds reported for Jun 30 · net +99 sh shares · +1 new
Insider flow
Distributing
Net -$232.9K over 90 days · 100% sells
Short interest
Falling
15.27% of float · ▼ -2.6% MoM · 5.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
213 holders — near 1-yr high, broad support
Price context
position in its 52-week range
52-wk low $4
Now $4 · 1%
52-wk high $23
vs 200-day avg -49%
vs 50-day avg -14%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Cash, restricted cash and marketable securities non-GAAP | $264.8M | the third quarter | — |
| Cash and marketable securities non-GAAP | $291.6M | the second quarter | — |
| Net (Debt) Cash Position non-GAAP | $27.4M | the second quarter | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TLRY
this stock
Tilray Brands, Inc.
|
$515.15M | -51.1% | +4.1% | — | 15.3% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$52.88B | +6.2% | — | — | 0.2% |
|
GALDY
Galderma Group AG/ADR
|
$50.15B | +3.2% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$42.98B | -3.5% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TLRY | -4.3% | -12.0% | -54.5% | -1.6% | -51.1% |
| SPY | +1.4% | +4.1% | +9.1% | +1.1% | +10.7% |
| vs SPY | -5.7% | -16.0% | -63.5% | -2.7% | -61.8% |